Dr. Weinstock Attends Press Conference Promoting Access of Cannabidiol for Severe EpilepsyPosted: June 29, 2018
Dr. Arie Weinstock, section chief of child neurology and director of the epilepsy program for the Dept. of Neurology, Jacobs School of Medicine and Biomedical Sciences, Univ. at Buffalo/SUNY, attended a press conference on June 29, 2018 to advocate for easy access of Epidiolex, a cannabidiol preparation that has received approval from the FDA for treatment of two forms of severe childhood epilepsy. Also at the press conference were NY Assemblyman Sean Ryan and NY State Senator Chris Jacobs. Dr. Weinstock and his team were part of the clinical trials that demonstrated the effectiveness of this form of medical marijuana in Lennox Gastaut and Dravet syndromes, two severe forms of epilepsy seen in children. The press conference requested that Governor Cuomo sign into law legislation already passed in Albany to expedite access to this new therapy.